|
End-of-day quote
London S.E.
|
||
| - GBX | - |
|
| 09:03am | Chugai grants GSK exclusive global license for AID351 dengue antibody | AN |
| 17/08 | FTSE 100 drifts lower as oil price pushes higher | AN |
Upcoming events on GlaxoSmithKline plc
| 28/10/2026 | Earnings release - Q3 2026 | |
| 03/02/2027 | Earnings release - Q4 2026 |
Past events on GlaxoSmithKline plc
| 28/07/2026 | Earnings release - Q2 2026 | 04:30 pm |
| 28/07/2026 | Earnings presentation | 06:30 pm |
| 28/05/2026 | Information meeting | 07:30 pm |
| 06/05/2026 | Présentation aux Actionnaires / Analystes | 07:00 pm |
| 06/05/2026 | Annual General Meeting | |
| 29/04/2026 | Earnings release - Q1 2026 | 11:30 am |
| 29/04/2026 | Earnings presentation | 04:30 pm |
| 04/02/2026 | Earnings release - Q4 2025 | 12:30 pm |
| 04/02/2026 | Earnings presentation | 04:30 pm |
| 29/10/2025 | Earnings presentation | 05:30 pm |
| 29/10/2025 | Earnings release - Q3 2025 |
Past dividends on GlaxoSmithKline plc
| 13/08/2026 | Ex-dividend date - 0.17 GBX | 09:30 am |
| 14/05/2026 | Ex-dividend date - 0.17 GBX | 09:30 am |
| 19/02/2026 | Ex-dividend date - 0.18 GBX | 10:30 am |
| 13/11/2025 | Ex-dividend date - 0.16 GBX | 10:30 am |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 30 328 29 850 1.6% | 31 376 31 163 0.68% | 32 667 32 506 0.49% | 33 942 | 35 540 | 36 692 |
|
EBITDA Million GBP | Released Forecast Spread | 11 635 10 203 14.04% | 10 693 10 130 5.56% | 11 278 11 236 0.38% | 11 467 | 12 286 | 12 727 |
|
EBIT Million GBP | Released Forecast Spread | 8 786 8 780 0.07% | 9 148 9 011 1.52% | 9 783 9 649 1.39% | 10 301 | 11 074 | 11 551 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 6 064 7 498 -19.12% | 3 477 4 752 -26.83% | 7 401 6 933 6.76% | 7 124 | 8 045 | 9 212 |
|
Net income Million GBP | Released Forecast Spread | 4 928 5 481 -10.09% | 2 575 3 509 -26.63% | 5 716 5 699 0.3% | 5 436 | 6 484 | 6 933 |
|
EPS GBP | Released Forecast Spread | 1,22 1,38 -11.61% | 0,63 0,85 -25.46% | 1,41 1,39 1.59% | 1,32 | 1,62 | 1,73 |
| Announcement Date | 31/01/24 | 05/02/25 | 04/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 S1 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 8 117 7 751 4.73% | 7 516 7 455 0.82% | 7 986 7 806 2.31% | 15 502 15 236 1.75% | 8 547 8 251 3.59% | 8 618 8 452 1.96% | 7 629 7 612 0.22% | 8 409 8 323 1.03% | 16 038 | 8 906 | 8 979 | 8 120 | 8 745 | 9 215 | 9 230 |
|
EBITDA Million GBP | Released Forecast Spread | 837 1 650 -49.29% | 3 356 2 603 28.94% | 3 790 2 700 40.37% | 3 723 2 958 25.86% | 409 1 769 -76.87% | 3 113 2 740 13.62% | 5 090 2 961 71.92% | 3 283 | 2 359 | ||||||
|
EBIT Million GBP | Released Forecast Spread | 1 431 1 330 7.6% | 2 533 2 302 10.03% | 2 631 2 458 7.03% | 5 164 5 033 2.59% | 2 985 2 647 12.76% | 1 634 1 490 9.69% | 2 650 2 480 6.87% | 2 800 2 692 4.02% | 5 450 | 2 976 | 1 916 | 2 930 | 2 957 | 3 362 | 1 924 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 563 919 -38.74% | 2 108 | 2 456 2 396 2.5% | 950 | 2 144 2 020 6.14% | 354 2 095 -83.1% | 1 797 | 790 | |||||||
|
Net income Million GBP | Released Forecast Spread | 414 750 -44.82% | 1 624 1 349 20.39% | 1 443 1 396 3.38% | 2 013 1 672 20.38% | 636 835 -23.84% | 1 737 1 489 16.62% | 435 1 636 -73.41% | 1 708 | 1 018 | ||||||
|
EPS GBP | Released Forecast Spread | 0,10 0,18 -44.32% | 0,39 0,32 20.94% | 0,35 0,34 3.54% | 0,50 0,41 22% | 0,16 0,20 -22.5% | 0,43 0,37 18.02% | 0,11 0,40 -73.52% | 0,42 | 0,25 | ||||||
| Announcement Date | 05/02/25 | 30/04/25 | 30/07/25 | 30/07/25 | 29/10/25 | 04/02/26 | 29/04/26 | 28/07/26 | 28/07/26 | - | - | - | - | - | - |
| 19/08/2026 |  | Earnings release - Q2 2026 | |
| 19/08/2026 | | Board of Directors Meeting | |
| 19/08/2026 | | Earnings release - Q2 2026 | |
| 19/08/2026 | | Board of Directors Meeting | |
| 19/08/2026 | | Information meeting | 09:00 am |
| 19/08/2026 | | Earnings presentation | 07:30 am |
| 20/08/2026 | | Earnings release - Q2 2026 | |
| 20/08/2026 | | Board of Directors Meeting | |
| 20/08/2026 | | Extraordinary General Meeting | 11:30 am |
| 20/08/2026 | | Earnings presentation | 05:00 pm |
Past sector events for GlaxoSmithKline plc
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Extraordinary General Meeting | 11:30 am |
| 17/08/2026 | | Board of Directors Meeting | |
| 17/08/2026 | | Earnings release - Q2 2026 | |
| 17/08/2026 | | Extraordinary General Meeting | 12:00 pm |
| 17/08/2026 | | Extraordinary General Meeting | |
| 17/08/2026 | | Significant Split/Dividend | 09:30 am |
| 17/08/2026 | | Ex-dividend date - 1.74669 TWD | 09:30 am |
| 15/08/2026 | | Earnings release - Q2 2026 |
- Stock Market
- Stocks
- GSK Stock
- Stock
- Calendar GlaxoSmithKline plc
Select your edition
All financial news and data tailored to specific country editions
